Savient Pharmaceuticals, Inc. (NASDAQ:SVNT)

CAPS Rating: 3 out of 5

A biopharmaceutical company engaged in developing and distributing pharmaceutical products that target unmet medical needs in both niche and broader markets.

Recs

0
Player Avatar t0bes (< 20) Submitted: 1/28/2011 5:36:40 PM : Outperform Start Price: $9.18 SVNT Score: -93.79

Potential

Featured Broker Partners


Advertisement